(A) Intact HeLa cells (Treacle-positive) were fixed and co-immunostained with Treacle and with either RPA194, UBF, fibrillarin, B23, or nucleolin antibodies. DNA was stained with DAPI (gray). Cells …
(A) HeLa cells were transfected with a construct coding CRISPR/Cas9 and single guide RNA (sgRNA) to the TCOF1 gene. 7–10 days after transfection, the cells were fixed and co-immunostained with …
(A) HeLa cells were transfected with a construct encoding CRISPR/Cas9 and a mock single guide RNA (sgRNA). 7–10 days post-transfection, cells were fixed, immunostained with IgG antibodies, and …
(A) The structure of the most common isoform of Treacle. Treacle isoform d (1488 amino acids, 152 kDa, NP_001128715.1) is encoded by the Treacle transcript variant 4. It is an intrinsically …
(A) Full-length Treacle disorder characteristics predicted by FuzDrop, Anchor2, and IUprep2. (B) HeLa cells were transfected with FusionRed-Cry2 or FUS-FusionRed-Cry2 constructs and, 24 hr after …
(A) HeLa cells were transfected with Treacle-2S Δ1–83 deletion mutant. For low or high levels expression analysis cells were cultivated 16–24 or 48 hr after transfection respectively. The expression …
(A) HeLa cells were transfected with full-length Treacle-2S. For low or high levels expression analysis cells were cultivated 16–24 or 48 hr after transfection respectively. The expression level is …
(A) HeLa cells were transfected with Treacle-2S. For low or high levels expression analysis, cells were cultivated 16–24 or 48 hr after transfection respectively. The expression level is indicated …
(A) HeLa cells were transfected with Treacle-2S ΔSE mutant. For low or high levels expression analysis cells were cultivated 16–24 or 48 hr after transfection respectively. The expression level is …
(A) Endogenous Treacle was depleted by small interfering RNA (siRNA)-mediated knockdown (Treacle kd). Next, Treacle-depleted cells were transfected with siRNA-resistant full-length Treacle-2S …
(A) Endogenous Treacle was depleted by small interfering RNA (siRNA)-mediated knockdown (Treacle kd). After 3–6 days, knockdown efficiencies were analyzed by western blotting. Mock, scrambled …
TIFF file containing original western blots for panel A, indicating the relevant bands.
Original files for western blot analysis displayed in panel A.
(A) Endogenous Treacle was depleted by small interfering RNA (siRNA)-mediated knockdown (Treacle kd). Next, Treacle-depleted cells were transfected with siRNA-resistant full-length Treacle-2S …
(A) DMSO-treated and VP16-treated (90 μM, 30 min) HeLa cells were co-immunostained for Treacle (Treacle endogenous; magenta) and TOPBP1 (green) and analyzed by laser scanning confocal microscopy. …
(A) DMSO-treated and VP16-treated (90 μM, 30 min) HeLa cells were co-immunostained for Treacle (Treacle endogenous; magenta) and TOPBP1 (green) and analyzed by laser scanning confocal microscopy. …
(A) Intact HeLa cells, small interfering RNA (siRNA)-depleted for Treacle (Treacle kd) cells or CRISPR/Cas9-depleted for Treacle (Treacle kn) cells were treated with 90 μM VP16 for 30 min. Cells …
(A) Endogenous Treacle was depleted by small interfering RNA (siRNA)-mediated knockdown (Treacle kd). Next, Treacle-depleted cells were transfected with plasmid constructs encoding either …
TIFF file containing original western blots for panel B, indicating the relevant bands.
Original files for western blot analysis displayed in panel B.
Reagent type (species) or resource | Designation | Source or reference | Identifiers | Additional information |
---|---|---|---|---|
Cell line (Homo sapiens) | HeLa | ATCC | CCL-2, RRID:CVCL_0030 | Mycoplasma free |
Cell line (Homo sapiens) | MCF7 | ATCC | HTB-22, RRID:CVCL_0031 | Mycoplasma free |
Cell line (Homo sapiens) | Dermal fibroblast (normal, Adult) | Gift from Dr. M Lagarkova | Female 46XX, Mycoplasma free | |
Chemical compound, drug | Etoposide (VP16) | Sigma-Aldrich | E1383 | |
Chemical compound, drug | CX-5461 | Sigma-Aldrich | #5092650001 | |
Chemical compound, drug | Actinomycin D (AMD) | Sigma-Aldrich | A1410 | |
Chemical compound, drug | 1,6-Hexanediol (1,6-HD) | Sigma-Aldrich | #240117 | |
Chemical compound, drug | Ammonium acetate | Serva | #39750.01 | |
Chemical compound, drug | Hoechst 33342 | Sigma-Aldrich | #14533 | |
Chemical compound, drug | DAPI | Sigma-Aldrich | D9542 | |
Antibody | Anti-Treacle/TCOF1 (Mouse monoclonal) | Santa Cruz Biotechnology | sc-374536, RRID:AB_10987865 | ICC (1:500), WB (1: 5000), ChIP-qPCR |
Antibody | Anti-Treacle/TCOF1 (Rabbit polyclonal) | Sigma-Aldrich | HPA038237 | ICC (1:500) |
Antibody | Anti-RPA194 (Mouse monoclonal) | Santa Cruz Biotechnology | sc-48385, RRID:AB_675814 | ICC (1:50), ChIP-qPCR |
Antibody | Anti-UBF1 (Rabbit polyclonal) | Thermo Fisher | PA5-82245, RRID:AB_2789405 | ICC (1:200), ChIP-qPCR |
Antibody | Anti-Fibrillarin (Rabbit monoclonal) | Abcam | ab166630, RRID:AB_2928100 | ICC (1:500) |
Antibody | Anti-Nucleolin (Rabbit monoclonal) | Cell Signaling | 14574, RRID:AB_2798519 | ICC (1:500) |
Antibody | Anti-B23 (Mouse monoclonal) | Sigma-Aldrich | B0556, RRID:AB_2154872 | ICC (1:300) |
Antibody | Anti-TOPBP1 (Mouse monoclonal) | Santa Cruz Biotechnology | sc-271043, RRID:AB_10610636 | ICC (1:200), ChIP-qPCR, WB (1:2500) |
Antibody | Anti-BRCA1 (Mouse monoclonal) | Santa Cruz Biotechnology | sc-6954, RRID:AB_626761 | ChIP-qPCR |
Antibody | Anti-pATM (Ser1981) (Mouse monoclonal) | Cell Signaling | 4526, RRID:AB_2062663 | ChIP-qPCR |
Antibody | Anti-γH2AX (Ser139) (Mouse monoclonal) | Millipore | 05-636, RRID:AB_309864 | ChIP-qPCR |
Antibody | Anti-pATR (Thr1989) (Rabbit polyclonal) | Cell Signaling | 58014, RRID:AB_2722679 | ChIP-qPCR |
Antibody | Anti-53BP1 (Rabbit polyclonal) | Santa Cruz Biotechnology | sc-22760, RRID:AB_2256326 | ChIP-qPCR |
Antibody | Anti-Katushka2S (Rabbit polyclonal) | Eurogene | AB233, RRID:AB_2571743 | ChIP-seq |
Antibody | Anti-GAPDH, (Rabbit polyclonal) | Abcam | ab9485, RRID:AB_307275 | WB |
Antibody | Polyclonal Goat anti-mouse Alexa Fluor Plus 488 | Invitrogen | A32723, RRID:AB_2633275 | ICC (1:200) |
Antibody | Polyclonal Goat anti-mouse Alexa Fluor Plus 594 | Invitrogen | A32742, RRID:AB_2762825 | ICC (1:200) |
Antibody | Polyclonal Goat anti-rabbit CF488A | Biotium | #20012, RRID:AB_10853801 | ICC (1:200) |
Antibody | Polyclonal Goat anti-rabbit CF594 | Biotium | #20112, RRID:AB_10559190 | ICC (1:200) |
Commercial assay or kit | Duolink In Situ Detection Reagents Green | Sigma-Aldrich | DUO92014 | |
Commercial assay or kit | Click-i RNA Alexa Fluor 488 Imaging Kit | Thermo Fisher | C10329 | |
Software, algorithm | ImageJ (version 1.44) | https://imagej.net/ij/download.html | RRID:SCR_003070 | |
Software, algorithm | CellProfiler (version 4.2.8) | https://cellprofiler.org/releases | RRID:SCR_007358 | |
Software, algorithm | Bowtie (version 2.2.3) | https://bowtie-bio.sourceforge.net/bowtie2/index.shtml | RRID:SCR_016368 | |
Software, algorithm | SAMtools (version 1.5) | https://github.com/samtools/samtools | RRID:SCR_002105 | |
Software, algorithm | deepTools (version 3.4.2) | https://github.com/deeptools/deepTools | RRID:SCR_016366 | |
Other | Lipofectamine LTX and Plus Reagent | Invitrogen | #15338-100 | |
Other | Lipofectamine 3000 | Invitrogen | L3000-015 |
Abbreviations: ICC, immunocytochemistry; ChIP, chromatin immunoprecipitation; WB: western blotting.
List of primers used for cloning.
The amino acid substitutions and deletions engineered to generate the Treacle ΔSE and Treacle CS mutant variants.
List of primers used for knockdown and knockout.
List of primers used for quantitative polymerase chain reaction (qPCR).
List of primers used for chromatin immunoprecipitation (ChIP)-quantitative polymerase chain reaction (qPCR).
List FITS-labeled oligonucleotides used for single-molecule fluorescence in situ hybridization (smFISH).